POMPANO BEACH

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

Retrieved on: 
Thursday, December 14, 2023
AW2, Lead, MAC, Learning, Health care, Regenerative medicine, Wound healing, Health, Medicare, ASP, Patient, OTC, CMS, Environment, Pharmaceutical industry

POMPANO BEACH, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Services (CMS) has established national pricing for its product, AmnioWrap2™, in all Medicare Administrative Contractors (MAC) regions.

Key Points: 
  • POMPANO BEACH, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Services (CMS) has established national pricing for its product, AmnioWrap2™, in all Medicare Administrative Contractors (MAC) regions.
  • BioStem exclusively commercializes AmnioWrap2™ through Venture Medical LLC, an innovative solutions provider in the U.S. wound care market with an extensive wound care-focused team.
  • Jason Matuszewski, CEO of BioStem Technologies Inc., expressed the significance of this achievement, highlighting the benefit it brings to Medicare patients across the United States.
  • “This change means that AmnioWrap2™ (AW2) can now be offered to all Medicare providers throughout the country.

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

Retrieved on: 
Wednesday, December 13, 2023
AdvaMed, Portable ultrasound, Wound healing, Regenerative medicine, Smith, Amputation, Face, Wound, Growth, OTC, Covidien, MITA, Management

(OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.

Key Points: 
  • (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.
  • Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition.
  • BioStem Technologies CEO, Jason Matuszewski, said, “I am delighted to welcome Mr. Dugan to BioStem’s Board of Directors.
  • Mr. Dugan served on the board of directors of Rita Medical Systems (NASDAQ: RITA), which was acquired by AngioDynamics, and various venture-backed medical device companies.

BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

Retrieved on: 
Wednesday, November 8, 2023
HCPCS, Medicare, HCPCS Level 2, OTC, Blue Cross Blue Shield Association, North American Pet Health Insurance Association, Healthcare Common Procedure Coding System, Centers for Medicare & Medicaid Services, Regenerative medicine, CMS, Pharmaceutical industry

(OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announced that the Centers for Medicare and Medicaid Services (CMS) has published a new Q code, Q4279 for VENDAJE AC® pursuant to its application for Healthcare Common Procedure Coding System (HCPCS) “Q” codes.

Key Points: 
  • (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announced that the Centers for Medicare and Medicaid Services (CMS) has published a new Q code, Q4279 for VENDAJE AC® pursuant to its application for Healthcare Common Procedure Coding System (HCPCS) “Q” codes.
  • The HCPCS code assigned for VENDAJE AC® will be effective January 1st, 2024.
  • VENDAJE AC is a human connective tissue matrix comprised of dehydrated amniotic/chorionic tissue processed using BioStem’s proprietary BioREtain® process.
  • "Securing the CMS Q code for our VENDAJE AC® tissue allograft marks yet another win for BioStem Technologies and ensures broader access to another top-tier wound care product within our portfolio,” said Biostem Technologies CEO Jason Matuszewski.

BioStem Technologies Closes Oversubscribed $2M Private Placement

Retrieved on: 
Friday, November 3, 2023
Unit, OTC, Regenerative medicine, Warrant, Security (finance)

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has closed an oversubscribed private placement of common stock to accredited investors for an aggregate of 1,337,000 units (each, a “Unit”) at a price of $1.50 per Unit for gross proceeds of $2 million.

Key Points: 
  • POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has closed an oversubscribed private placement of common stock to accredited investors for an aggregate of 1,337,000 units (each, a “Unit”) at a price of $1.50 per Unit for gross proceeds of $2 million.
  • Each Unit consists of one common share in the capital of the Company (each, a “Share”) and one common share purchase warrant (each, a “Warrant”) at $1.50 per Share and $2.00 per Warrant.
  • The Company intends to use the net proceeds from this private placement to complete clinical trials to support product performance, expand brand awareness and product distribution, and execute product pipeline plans.

Curonix Celebrates 1st Anniversary

Retrieved on: 
Wednesday, November 1, 2023
SCS, Education, Jessika Carr, PNS, Freedom, Physician, American Medical Association, AMA, Society, HF, Safety, Patient, Nursing, Pharmaceutical industry

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.

Key Points: 
  • POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary.
  • In November 2022, Curonix completed the purchase of substantially all assets, excluding liabilities, of Stimwave Technologies.
  • “Curonix is a new company that was formed to deliver much-needed non-opioid chronic pain relief with our innovative HF-EMC technology platform.
  • “We are excited to support Curonix as it serves patients and physicians,” said David Kho, Curonix Chairman of the Board, and Managing Director at Kennedy Lewis.

Brownie’s Marine Group exceeded expectations and saw an increase in interest at the 2023 Annapolis boat shows

Retrieved on: 
Monday, October 23, 2023
Maintenance, Nemo, Diving, Whaling, Online shopping, Dredging

Brownie’s Marine Group continues to target boaters and scuba divers with a consistent presence at boat shows around the country.

Key Points: 
  • Brownie’s Marine Group continues to target boaters and scuba divers with a consistent presence at boat shows around the country.
  • After attending the Annapolis Powerboat and Sailboat Show for the fifth consecutive year, Brownie’s Marine Group experienced an increase in interest at the 2023 Annapolis shows.
  • Brownie’s Third Lung also experienced an increase in sales during the Annapolis Boat Shows with many resulting from conversations started in prior year’s shows.
  • Based on the success from the 2023 Annapolis Boat Shows, Brownie’s Marine Group believes that this trend will continue as the concept and brands continue to grow.

Boise Cascade adds new distribution warehouse in West Palm Beach, FL

Retrieved on: 
Friday, October 20, 2023
Forest Products, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Natural Resources, Construction & Property, BMD, Boise Cascade, BCC, NYSE

Boise Cascade Company’s (NYSE: BCC) Building Materials Distribution (BMD) division announced today that it has completed the purchase of a new 120,000 sq.

Key Points: 
  • Boise Cascade Company’s (NYSE: BCC) Building Materials Distribution (BMD) division announced today that it has completed the purchase of a new 120,000 sq.
  • ft. warehouse and distribution facility in West Palm Beach, FL.
  • The total property is 9.7 acres and will provide additional storage and service capacity for the Pompano Beach branch.
  • “We are excited for the opportunity to open this new distribution facility for Boise Cascade and join the West Palm Beach community,” said Chuck Donaldson, Branch Manager.

THE CORDISH COMPANIES AND CAESARS ENTERTAINMENT PRESENT $150K IN LOCAL IMPACT AND COMMUNITY GRANTS TO ORGANIZATIONS IN POMPANO BEACH COMMUNITIES SURROUNDING 'THE POMP'

Retrieved on: 
Tuesday, October 17, 2023
Partnership, Pointe Orlando, Knowledge, Secretary of State of Florida, Pomp, Orange County Convention Center, Hard Rock Cafe, McArthur, Music, Bay, Vivo, Environment, Kenneth A. McArthur, Seminole, Hotel, Cordish

POMPANO BEACH, Fla., Oct. 17, 2023 /PRNewswire/ -- The Cordish Companies and Caesars Entertainment have awarded $150,000 to organizations in the Pompano Beach community through its Community Charitable Funding Grant program. Established to provide valuable resources to communities surrounding The Pomp, a 223-acre world-class destination currently under construction in Pompano Beach, the grants aim to help local organizations in Collier City, Cypress Bend, Palm Aire and Pompano Beach make a significant difference through community revitalization and beautification, traffic and public safety improvements, and community service programs. Cordish Chief Operating Officer Zed Smith, Senior Vice President of Caesars Entertainment Troy Buswell, and members of The Pomp Community Advisory Board presented the grants to recipients at a grantee ceremony, held last week in Pompano Beach.

Key Points: 
  • This not only enriches the initiatives that receive funding, but also equips the community with skills and knowledge they can apply in future endeavors.
  • It is McArthur's Own's firm belief that the impact of this collaborative effort will be multidimensional—addressing social, economic, and even environmental aspects of community well-being.
  • at The Pomp — will bring together entertainment, dining, hotel, retail, residential, office and lifestyle amenities, alongside the successful Harrah's Pompano Beach casino, in one world-class destination.
  • at The Pomp and Harrah's Pompano Beach, Topgolf will also anchor the Pompano Beach development with their eighth Florida location.

Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

Retrieved on: 
Thursday, October 12, 2023

Further, an additional report by Allied Market Research stated the global car t-cell therapy market size was valued at $1.7 billion in 2021, and is projected to reach $6.1 billion by 2031.

Key Points: 
  • Further, an additional report by Allied Market Research stated the global car t-cell therapy market size was valued at $1.7 billion in 2021, and is projected to reach $6.1 billion by 2031.
  • Precedence Research added: “The growth of global cell therapy market is attributed to the rising incidents of chronic disorders and infections.
  • Moreover, the growing number of research studies and clinical trials are also boosting the growth of global cell therapy market.
  • One of the key factors propelling the expansion of global cell therapy market is adoption of innovative and latest technologies.